Clinical Trial Update: ENgineered Tissue Repair of BronchopleUral FiSTula [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating engineered tissue repair for bronchopleural fistula has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopleural Fistula

Drugs mentioned

• Videregen engineered tissue repair product

Snippet

Sponsor: Videregen Limited | Conditions: Bronchopleural Fistula | Phase 1, Phase 2 | Status: WITHDRAWN